Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NAD Supplementation to Reduce the Incidence of Cardiac Surgery Associated Acute Kidney Injury

NCT07739290 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT07739290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07739290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NAD Supplementation to Reduce the Incidence of Cardiac Surgery Associated Acute Kidney Injury
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
January 1, 2029
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury